Mieczkowska, I. K., Pantelaiou-Prokaki, G., Prokakis, E., Schmidt, G. E., Müller-Kirschbaum, L. C., Werner, M., . . . Wegwitz, F. (2021). Decreased PRC2 activity supports the survival of basal-like breast cancer cells to cytotoxic treatments. Cell Death and Disease, 12(12), 1-13. https://doi.org/10.1038/s41419-021-04407-y

Mieczkowska, Iga K., et al. "Decreased PRC2 Activity Supports the Survival of Basal-like Breast Cancer Cells to Cytotoxic Treatments." Cell Death and Disease 12, no. 12 (2021): 1-13. https://doi.org/10.1038/s41419-021-04407-y.

Mieczkowska, Iga K., et al. "Decreased PRC2 Activity Supports the Survival of Basal-like Breast Cancer Cells to Cytotoxic Treatments." Cell Death and Disease, vol. 12, no. 12, 2021, pp. 1-13, https://doi.org/10.1038/s41419-021-04407-y.